Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Terlipressin Acetate, a highly selective vasopressin V1 receptor agonist, on oxygen and glucose deprivation/re-oxygenation (OGD/R)-induced damage in intestinal epithelial cells (IEC-6).Terlipressin acetate exerts anti-inflammatory and anti-oxidative effects. Terlipressin acetate has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 41.00 | |
10 mg | In stock | $ 56.00 | |
25 mg | In stock | $ 105.00 | |
50 mg | In stock | $ 138.00 | |
100 mg | In stock | $ 218.00 | |
200 mg | In stock | $ 327.00 |
Description | Terlipressin Acetate, a highly selective vasopressin V1 receptor agonist, on oxygen and glucose deprivation/re-oxygenation (OGD/R)-induced damage in intestinal epithelial cells (IEC-6).Terlipressin acetate exerts anti-inflammatory and anti-oxidative effects. Terlipressin acetate has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research. |
In vitro | Incubation with 25 nM terlipressin significantly improved cell viability, proliferation and apoptosis. Furthermore, terlipressin inhibited the secretion of TNF-α and 15-F2t-isoprostane from IEC-6 cells following OGD/R[1]. |
In vivo | Using a mouse nonlethal hepatic IR model, we found terlipressin administration significantly ameliorated IR-induced liver apoptosis, necrosis and inflammation[2]. |
Synonyms | Terlipressin diacetate anhydrous, Terlipressin acetate anhydrous |
Molecular Weight | 1347.5 |
Formula | C56H82N16O19S2 |
CAS No. | 1884420-36-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 95mg/mL (70.50mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Terlipressin Acetate 1884420-36-3 GPCR/G Protein Vasopressin Receptor variceal hepatorenal vasoconstriction Terlipressin diacetate anhydrous acute anti-inflammatory bleeding anti-oxidative Inhibitor vasopressin Terlipressin acetate anhydrous Vasoconstrictor Terlipressin V1-receptors inhibit inhibitor